MASP1 (protein)

Last updated
MASP1
Available structures
PDB Human UniProt search: PDBe RCSB
Identifiers
Aliases MASP1 , 3MC1, CRARF, CRARF1, MAP1, MASP, MASP3, MAp44, PRSS5, RaRF, mannan binding lectin serine peptidase 1, Mannan-binding lectin serine protease 1, MBL associated serine protease 1, MASP-3, MAP-1
External IDs OMIM: 600521 HomoloGene: 89143 GeneCards: MASP1
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001031849
NM_001879
NM_139125

n/a

RefSeq (protein)

NP_001027019
NP_001870
NP_624302

n/a

Location (UCSC) Chr 3: 187.22 – 187.29 Mb n/a
PubMed search [2] n/a
Wikidata
View/Edit Human

Mannan-binding lectin serine protease 1 also known as mannose-associated serine protease 1 (MASP-1) is an enzyme that in humans is encoded by the MASP1 gene. [3] [4] [5]

Contents

MASP-1 is involved in the lectin pathway of the complement system and is responsible for activating MASP-2 and MASP-3. [6] It is also involved in the process of cleaving complement proteins, C4 and C2, into fragments to form a C3-convertase. [7]

Function

MASP-1 is a serine protease that functions as a component of the lectin pathway of complement activation. The complement pathway plays an essential role in the innate and adaptive immune response as it allows the body to clear foreign material. [8] MASP-1 is synthesized as a zymogen and is activated when it creates a complex of proteins with the pathogen recognition molecules oft the lectin pathway: the mannose-binding lectin and the ficolins. This protein is directly involved in complement activation because MASP-1 activates MASP-2 by cleaving (cutting off a piece) a MASP-2 zymogen. [9] MASP-2 is then able to cleave C4 into proteins C4a and C4b. MASP-1 is also responsible for creating C3 convertase by cleaving C2 into C2b and C2a. C2a and C4b are used to create C3 convertase, a complex that will then be able to cleave C3 into C3a and C3b. However, MASP-1 is useful for biological pathways other than the complement pathway, such as blood clots. MASP-1 can cleave coagulation pathway proteins such as PAR-4, fibrinogen, and factor XIII which leads to high clot and fibrin generation. [10] [9] A spliced variant of this gene, which lacks the serine protease domain, functions as an inhibitor of the complement pathway. [5]

Structure

MASP-1’s structure is similar to other MASP proteins. The MASP1 gene encodes MASP-1 as well as MASP-3 (via alternative splicing). [11] Despite being made from different genes and spliced genes, all MASP proteins have the same structure of a heavy/alpha chain, a light/beta chain, and an interconnecting cysteine disulfide bond. The heavy chain is made up of two CUB domains and two complement control protein (CCP) domains that are connected by an epidermal growth factor segment (EGF). However, the full crystal structure of MASP proteins has not yet been formulated. [12]

Clinical significance

MASP1 gene changes can lead to several diseases in patients due to subsequent MASP-1 protein changes. MASP1 gene changes (polymorphisms) can lead to systemic inflammatory response syndrome (SIRS)/sepsis, malpuech facial clefting (3MC) syndrome, and bacterial colonization in those with cystic fibrosis. Also, MASP-1 is essential for stem cell transplantation as it is involved in the transportation of bone marrow stem cells to the blood. [13] Furthermore, single-nucleotide polymorphisms (SNPs) in MASP1 genes can lead to impaired blood clotting and complement activation. [14] Overproduction of MASP-1 proteins can also be related to some diseases. For example, cardiovascular diseases increase MASP-1 levels, especially in cases such as subacute myocardial infarction. MASP-1 is also upregulated in patients with uterine leiomyosarcoma, and it can potentially activate the alternative pathway of complement in inflammatory arthritis patients. Hepatitis C (HCV), a liver disease, is associated with MASP-1 due to the localization of high concentrations of MASP-1 in infected livers. Higher levels of MASP-1 correlated with severe HCV-related liver fibrosis. [14]

See also

Related Research Articles

<span class="mw-page-title-main">Complement system</span> Part of the immune system that enhances the ability of antibodies and phagocytic cells

The complement system, also known as complement cascade, is a part of the immune system that enhances (complements) the ability of antibodies and phagocytic cells to clear microbes and damaged cells from an organism, promote inflammation, and attack the pathogen's cell membrane. It is part of the innate immune system, which is not adaptable and does not change during an individual's lifetime. The complement system can, however, be recruited and brought into action by antibodies generated by the adaptive immune system.

<span class="mw-page-title-main">C3-convertase</span>

C3 convertase belongs to family of serine proteases and is necessary in innate immunity as a part of the complement system which eventuate in opsonisation of particles, release of inflammatory peptides, C5 convertase formation and cell lysis.

Pattern recognition receptors (PRRs) play a crucial role in the proper function of the innate immune system. PRRs are germline-encoded host sensors, which detect molecules typical for the pathogens. They are proteins expressed mainly by cells of the innate immune system, such as dendritic cells, macrophages, monocytes, neutrophils, as well as by epithelial cells, to identify two classes of molecules: pathogen-associated molecular patterns (PAMPs), which are associated with microbial pathogens, and damage-associated molecular patterns (DAMPs), which are associated with components of host's cells that are released during cell damage or death. They are also called primitive pattern recognition receptors because they evolved before other parts of the immune system, particularly before adaptive immunity. PRRs also mediate the initiation of antigen-specific adaptive immune response and release of inflammatory cytokines.

<span class="mw-page-title-main">Lectin pathway</span>

The lectin pathway or MBL pathway is a type of cascade reaction in the complement system, similar in structure to the classical complement pathway, in that, after activation, it proceeds through the action of C4 and C2 to produce activated complement proteins further down the cascade. In contrast to the classical complement pathway, the lectin pathway does not recognize an antibody bound to its target. The lectin pathway starts with mannose-binding lectin (MBL) or ficolin binding to certain sugars.

<span class="mw-page-title-main">Complement component 1r</span> Protein-coding gene in humans

Complement C1r subcomponent is a protein involved in the complement system of the innate immune system. In humans, C1r is encoded by the C1R gene.

<span class="mw-page-title-main">Complement component 1s</span> Protein found in humans

Complement component 1s is a protein involved in the complement system. C1s is part of the C1 complex. In humans, it is encoded by the C1S gene.

<span class="mw-page-title-main">MASP2 (protein)</span> Protein-coding gene in the species Homo sapiens

Mannan-binding lectin serine protease 2 also known as mannose-binding protein-associated serine protease 2 (MASP-2) is an enzyme that in humans is encoded by the MASP2 gene.

Mannose-binding protein-associated serine protease are serine proteases involved in the complement system.

<span class="mw-page-title-main">Factor D</span> Class of enzymes

Factor D is a protein which in humans is encoded by the CFD gene. Factor D is involved in the alternative complement pathway of the complement system where it cleaves factor B.

Collectins (collagen-containing C-type lectins) are a part of the innate immune system. They form a family of collagenous Ca2+-dependent defense lectins, which are found in animals. Collectins are soluble pattern recognition receptors (PRRs). Their function is to bind to oligosaccharide structure or lipids that are on the surface of microorganisms. Like other PRRs they bind pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs) of oligosaccharide origin. Binding of collectins to microorganisms may trigger elimination of microorganisms by aggregation, complement activation, opsonization, activation of phagocytosis, or inhibition of microbial growth. Other functions of collectins are modulation of inflammatory, allergic responses, adaptive immune system and clearance of apoptotic cells.

<span class="mw-page-title-main">Mannan-binding lectin</span> Mammalian protein found in Homo sapiens

Mannose-binding lectin (MBL), also called mannan-binding lectin or mannan-binding protein (MBP), is a lectin that is instrumental in innate immunity as an opsonin and via the lectin pathway.

The mannose receptor is a C-type lectin primarily present on the surface of macrophages, immature dendritic cells and liver sinusoidal endothelial cells, but is also expressed on the surface of skin cells such as human dermal fibroblasts and keratinocytes. It is the first member of a family of endocytic receptors that includes Endo180 (CD280), M-type PLA2R, and DEC-205 (CD205).

<span class="mw-page-title-main">FCN2</span> Protein-coding gene in the species Homo sapiens

Ficolin-2, which was initially identified as L-ficolin, is a protein that in humans is encoded by the FCN2 gene.

<span class="mw-page-title-main">FCN1</span> Protein-coding gene in the species Homo sapiens

Ficolin-1, and also commonly termed M-ficolin is a protein that in humans is encoded by the FCN1 gene.

<span class="mw-page-title-main">C3a (complement)</span>

C3a is one of the proteins formed by the cleavage of complement component 3; the other is C3b. C3a is a 77 residue anaphylatoxin that binds to the C3a receptor (C3aR), a class A G protein-coupled receptor. It plays a large role in the immune response.

Mannose-binding lectin-associated protein of 44 kDa (MAp44) is a protein arising from the human MASP1 gene. MASP-1, MASP-3 and MAp44 are alternative splice products of the MASP1 gene. MAp44 has been suggested to act as a competitive inhibitor of lectin pathway activation, by displacing MASP-2 from MBL, hence preventing cleavage of C4 and C2

Ficolins are pattern recognition receptors that bind to acetyl groups present in the carbohydrates of bacterial surfaces and mediate activation of the lectin pathway of the complement cascade.

<span class="mw-page-title-main">Glutamyl endopeptidase GluV8</span>

Glutamyl endopeptidase is an extracellular bacterial serine protease of the glutamyl endopeptidase I family that was initially isolated from the Staphylococcus aureus strain V8. The protease is, hence, commonly referred to as "V8 protease", or alternatively SspA from its corresponding gene.

Mannan-binding lectin-associated serine protease-2 is an enzyme. This enzyme catalyses the following chemical reaction

<span class="mw-page-title-main">Aureolysin</span>

Aureolysin is an extracellular metalloprotease expressed by Staphylococcus aureus. This protease is a major contributor to the bacterium's virulence, or ability to cause disease, by cleaving host factors of the innate immune system as well as regulating S. aureus secreted toxins and cell wall proteins. To catalyze its enzymatic activities, aureolysin requires zinc and calcium which it obtains from the extracellular environment within the host.

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000127241 - Ensembl, May 2017
  2. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  3. Takada F, Takayama Y, Hatsuse H, Kawakami M (October 1993). "A new member of the C1s family of complement proteins found in a bactericidal factor, Ra-reactive factor, in human serum". Biochemical and Biophysical Research Communications. 196 (2): 1003–1009. doi:10.1006/bbrc.1993.2349. PMID   8240317.
  4. Sato T, Endo Y, Matsushita M, Fujita T (April 1994). "Molecular characterization of a novel serine protease involved in activation of the complement system by mannose-binding protein". International Immunology. 6 (4): 665–669. doi:10.1093/intimm/6.4.665. PMID   8018603.
  5. 1 2 "Entrez Gene: mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor)".
  6. Sekine H, Takahashi M, Iwaki D, Fujita T (2013). "The Role of MASP-1/3 in Complement Activation". In Lambris JD, Holers VM, Ricklin D (eds.). Complement Therapeutics. Advances in Experimental Medicine and Biology. Vol. 735. New York, NY: Springer US. pp. 41–53. doi:10.1007/978-1-4614-4118-2_3. ISBN   978-1-4614-4118-2. PMID   23402018.
  7. Matsushita M, Thiel S, Jensenius JC, Terai I, Fujita T (September 2000). "Proteolytic activities of two types of mannose-binding lectin-associated serine protease". Journal of Immunology. 165 (5): 2637–2642. doi: 10.4049/jimmunol.165.5.2637 . PMID   10946292.
  8. Atik T, Koparir A, Bademci G, Foster J, Altunoglu U, Mutlu GY, et al. (September 2015). "Serine Proteases in the Lectin Pathway of the Complement System". Proteases in Physiology and Pathology. Vol. 10. pp. 397–420. doi:10.1007/978-981-10-2513-6_18. ISBN   978-981-10-2512-9. PMC   7120406 . PMID   26419238.{{cite book}}: |journal= ignored (help)
  9. 1 2 Dobó J, Schroeder V, Jenny L, Cervenak L, Závodszky P, Gál P (October 2014). "Multiple roles of complement MASP-1 at the interface of innate immune response and coagulation" (PDF). Molecular Immunology. XXV International Complement Workshop September 14-18, 2014 - Rio de Janeiro, Brazil. 61 (2): 69–78. doi:10.1016/j.molimm.2014.05.013. PMID   24935208.
  10. Kjaer TR, Thiel S, Andersen GR (December 2013). "Toward a structure-based comprehension of the lectin pathway of complement" (PDF). Molecular Immunology. 56 (4): 413–422. doi:10.1016/j.molimm.2013.05.007. PMID   23911397.
  11. Takahashi M, Mori S, Shigeta S, Fujita T (2007). "Role of MBL-associated Serine Protease (MASP) on Activation of the Lectin Complement Pathway". In Lambris JD (ed.). Current Topics in Innate Immunity. Advances in Experimental Medicine and Biology. Vol. 598. Springer. pp. 93–104. doi:10.1007/978-0-387-71767-8_8. ISBN   978-0-387-71767-8. PMID   17892207.
  12. Garred P, Genster N, Pilely K, Bayarri-Olmos R, Rosbjerg A, Ma YJ, Skjoedt MO (November 2016). "A journey through the lectin pathway of complement-MBL and beyond". Immunological Reviews. 274 (1): 74–97. doi:10.1111/imr.12468. PMID   27782323. S2CID   37084404.
  13. Cedzyński M, Świerzko AS (July 2020). "Components of the Lectin Pathway of Complement in Haematologic Malignancies". Cancers. 12 (7): 1792. doi: 10.3390/cancers12071792 . PMC   7408476 . PMID   32635486.
  14. 1 2 Beltrame MH, Boldt AB, Catarino SJ, Mendes HC, Boschmann SE, Goeldner I, Messias-Reason I (September 2015). "MBL-associated serine proteases (MASPs) and infectious diseases". Molecular Immunology. 15th European Meeting on Complement in Human Disease 2015, Uppsala, Sweden. 67 (1): 85–100. doi:10.1016/j.molimm.2015.03.245. PMC   7112674 . PMID   25862418.

Further reading

This article incorporates text from the United States National Library of Medicine, which is in the public domain.